AMA

Peter evaluates longevity drugs, aspirin for CVD, and strategies to improve muscle mass — promising, proven, fuzzy, noise, or nonsense?

Ep. #370 (AMA #76)

Free Article

A critical look at the lifespan-extending promise of psilocybin

Guest Episode

How metabolic and immune system dysfunction drive the aging process, the role of NAD, promising interventions, aging clocks, and more

Ep. #359 with Eric Verdin, M.D.

QPS

Peter’s takeaways on navigating HRT, rejuvenating the face, understanding the biology of aging, optimizing fertility, and learning to live well from the dying

Ep. #358

Guest Episode

A new era of longevity science: models of aging, human trials of rapamycin, biological clocks, promising compounds, and lifestyle interventions

Ep. #357 with Brian Kennedy, Ph.D.

Podcast Episode

Aging well: Peter shares strategies for improving longevity with residents at a senior living center

Ep. #342

Premium Article

Metformin as a potential longevity medication: where do we stand?

Guest Episode

Longevity roundtable — the science of aging, geroprotective molecules, lifestyle interventions, challenges in research, and more

Ep. #333 with Steven Austad, Ph.D., Matt Kaeberlein, Ph.D., Richard Miller, M.D., Ph.D.

AMA

Special AMA: Peter on exercise, important labs, building good habits, promising longevity research, and more

Ep. #329

Premium Article

Evaluating NAD and NAD precursors for health and longevity

Free Article

Failure of resveratrol to improve metabolic health is another nail in the coffin

Podcast Episode

Special episode: Peter on exercise, fasting, nutrition, stem cells, geroprotective drugs, and more — promising interventions or just noise?

Ep. #300

Guest Episode

Longevity drugs, aging biomarkers, and updated findings from the Interventions Testing Program (ITP)

Ep. #281 with Richard Miller M.D., Ph.D.

Free Article

Could an antihypertensive drug have independent benefits for longevity?

AMA

Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent

Ep. #246 (AMA #45)

Free Article

A recent metformin study casts doubts on longevity indications

The difference between a 'clean' drug and a 'dirty' drug

Guest Episode

Are there “biomarkers” for aging?

with Matt Kaeberlein, Ph.D.

AMA

"Anti-Aging" Drugs — NAD+, metformin, & rapamycin

Ep. #207 (AMA #35) with Matt Kaeberlein, Ph.D.

Guest Episode

The challenges of defining aging

with Matt Kaeberlein, Ph.D.

Guest Episode

Potential Risks of NAD Supplements

with Iñigo San-Millán, Ph.D.

Guest Episode

About TAME: A Metformin Anti-Aging Clinical Trial

with Nir Barzilai, M.D.

Guest Episode

Centenarians, metformin, and longevity

Ep. #204 with Nir Barzilai, M.D.

Guest Episode

The biology of aging, rapamycin, and other interventions that target the aging process

Ep. #175 with Matt Kaeberlein, Ph.D.